.Novo Nordisk has axed its once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) development o...
.Merck & Co. has swiftly recouped a number of the prices of its own Javelin Rehabs buyout, drawin...
.After BioMarin carried out a springtime clean of its pipe in April, the company has actually made a...
.Big Pharmas remain caught to the tip of molecular adhesive degraders. The current firm to observe a...
.A brand new international life science credit rating company, referred to Symbiotic Capital, has ac...
.Bristol Myers Squibb is actually axing one more huge bet coming from the Caforio era, ending a pack...
.After checking out at stage 1 information, Nuvation Bio has actually made a decision to halt focus ...
.Zevra Therapeutics' uncommon condition drug seems to be to be on the course to authorization this f...
.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics treatment failure has actually blown a ...
.After more than two decades of focus on neurodegenerative diseases, Swiss biotech AC Immune system ...